Maslan Andrew Scott 4
4 · CYTOMEDIX INC · Filed Jan 30, 2012
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI
Maslan Andrew Scott
Chief Financial Officer
Transactions
- Other
Common Stock
2012-01-17+232→ 69,897 total
Footnotes (1)
- [F1]Received pursuant to a stock dividend on the Company's outstanding Series D Convertible Preferred Stock.